TRANSCRIPTOME ANALYSIS OF IMMUNITY RELATED GENES AS EARLY PREDICTOR OF GRAFT VERSUS HOST DISEASE.

被引：0
|
作者：
Dharmani-Khan, Poonam [1 ]
Faridi, Rehan M. [1 ]
Akhter, Ariz [1 ]
Berka, Noureddine [1 ]
Storek, Jan [1 ]
Khan, Faisal M. [2 ]
机构：
[1] Univ Calgary, Med, Calgary, AB, Canada
[2] Univ Calgary, Pathol & Lab Med, Calgary, AB, Canada
来源：
HUMAN IMMUNOLOGY | 2016年 / 77卷
关键词：
D O I：
10.1016/j.humimm.2016.07.060
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OR41
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] Vaccine induced graft-versus-tumor effects are separable from graft-versus-host disease.
    Teshima, T
    Mach, N
    Hill, GR
    Dranoff, G
    Ferrara, JLM
    BLOOD, 1999, 94 (10) : 635A - 635A
  • [42] Periodontal disease might be a risk factor for graft versus host disease. A systematic review
    Mester, Alexandru
    Irimie, Alexandra Iulia
    Tanase, Alina
    Tranca, Sebastian
    Campian, Radu Septimiu
    Tomuleasa, Ciprian
    Dima, Delia
    Piciu, Andra
    Lucaciu, Ondine
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 147
  • [43] A murine model to investigate the mechanism of chronic-graft-versus-host disease.
    Anderson, BE
    Shlomchik, MJ
    Shlomchik, WD
    BLOOD, 2000, 96 (11) : 768A - 768A
  • [44] Efficacy of Mycophenolate Mofetil (MMF) in the treatment of chronic graft versus host disease.
    Lopez, F
    Parker, P
    Rodriguez, R
    Snyder, D
    Bhatia, R
    Cohen, S
    Fung, H
    Kashyap, A
    Krishnan, A
    Molina, A
    Nademanee, A
    O'Donnell, M
    Popplewell, L
    Rosenthal, J
    Sahebi, F
    Somlo, G
    Spielberger, R
    Stein, A
    Sweetman, R
    Forman, S
    BLOOD, 2001, 98 (11) : 398A - 398A
  • [45] Energy and substrate metabolism in patients with chronic extensive graft versus host disease.
    Zauner, C
    Rabitsch, W
    Schneeweiss, B
    Schiefermeier, M
    Greinix, HT
    Keil, F
    Ratheiser, K
    Kalhs, P
    BLOOD, 2000, 96 (11) : 194A - 194A
  • [46] Hepatocyte growth factor ameliorates chronic graft-versus-host disease.
    Imado, T
    Iwasaki, T
    Kuroiwa, T
    Okamoto, T
    Hara, H
    Sano, H
    BLOOD, 2004, 104 (11) : 831A - 831A
  • [47] GENITAL GRAFT VERSUS HOST DISEASE: ACUTE VERSUS EARLY ONSET CHRONIC DISEASE
    Lafond, S.
    Pulanic, Klepac T.
    Turner, M.
    Bishop, M.
    Fowler, D.
    Mackall, C.
    Stratton, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S344 - S344
  • [48] Role of interferon-gamma in the pathobiology of graft-versus-host disease.
    Murphy, WJ
    Longo, DL
    Blazar, BR
    FASEB JOURNAL, 1998, 12 (04): : A584 - A584
  • [49] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [50] The role of type I interferon in prophylaxis of graft-versus-host disease.
    Orberg, Erik Thiele
    Poeck, Hendrik
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345